Health Care Delivery

The data for this analysis on survivors of lung cancer came from Johns Hopkins Sidney Kimmel Comprehensive Cancer Center thoracic oncology clinics.

Presenters explored the real-world evidence in support of biosimilars at the Academy of Managed Care Pharmacy 2024 annual meeting.

While health plans often employ reimbursement rates as a tool to incentivize provider participation within their networks, study results showed reimbursement rates for office visits with medical/surgical clinicians were on average 22% higher than behavioral health clinicians.

Screening completion increased when using sequential automated and personalized strategies for colorectal cancer (CRC) in different demographic groups.

Large insurance sales agency call centers are accused of enrolling individuals in plans without consent; more young adults are choosing permanent contraception procedures; widespread frustration with prior authorization requirements hints at potential future measures.

Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.

In a registry-based analysis, more hospitalized children with SCD and COVID-19 had severe infection requiring supplemental oxygen, compared with the general population.

The University of Utah Drug Information Service reports an unprecedented rise in shortages; cultural ethos and modern pressures contribute to sleep deprivation across the nation; rising death rates underscore the urgent need for expanded access to prevention and treatment measures

This week the Center on Health Equity and Access spotlighted National Minority Health Month with the launch of a podcast and feature series. Also, new data on "deaths of despair," medication, and clinical access.

By prioritizing well-being, both the public and private sectors can come together in partnerships to address social needs and social determinants of health.

New research examining treatment initiation patterns among patients with axial spondyloarthritis revealed significant sex-based disparities, shedding light on the process from diagnosis to therapeutic intervention.

Ari Green, MD, University of California, San Francisco, discusses the promising results observed in current remyelination trials in multiple sclerosis (MS) and the patient-specific features that may influence therapy outcomes.

The introduction of momelotinib to treat myelofibrosis with anemia can result in small savings due to reduced transfusion-related costs, according to a budget impact model.

Nearly a quarter of adults disenrolled from Medicaid are now uninsured; a new bill in Alaska will allow primary care providers to offer care based on monthly fees; the CDC warns of a 17-fold increase in measles cases in the first quarter of 2024.

Treatment and management of multiple myeloma (MM) is continuously evolving, and in this analysis, investigators discuss ever-present issues and potential solutions to optimize care for this patient population.

A small, double-blind study has revealed the promise of the BAY2586116 nasal spray to help manage severe forms of obstructive sleep apnea and lower an individual’s morning blood pressure.

Funding proposal includes gene therapies for sickle cell disease (SCD); draft legislation aims to address long COVID challenges; efforts are underway to prevent a summer surge.

Authors conducted a systematic literature review to gather evidence on the appropriateness of recommended treatments for locally advanced non–small cell lung cancer (LA-NSCLC) from the American Radium Society Appropriate Use Criteria Thoracic Committee.

As CMS’ suite of value-based and accountable care models evolves, leaders from across the agency detailed how they are working together to streamline quality reporting and encourage the move to a population health mindset while addressing providers’ concerns.

This feature series delves into how biases shed light on deeply ingrained stereotypes and prejudices that exist within the structure of US maternal health care, according to experts.

Contrary to previous assumptions, the analysis found that mortality rates from deaths of despair among middle-aged Black Americans exceeded those of their White counterparts in 2022.

Pat Van Burkleo, the executive director of Feeding Louisiana, the Louisiana Food Bank Association, shares insight on legislative priorities and the impact food insecurity can have on health.

Lawmakers are under pressure to decide the fate of COVID-era telehealth payment changes; the CDC reports an alarming increase in sexually transmitted disease (STD) cases among Americans 55 years and older; new regulations aim to reduce harmful exposure to per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals.”

A retrospective cohort study assessed patterns of opioid use in children with sickle cell disease (SCD) following their initial opioid prescription for pain management, finding that concerning patterns of opioid abuse did not develop.

Previous research links type 2 diabetes and metabolic dysfunction–associated steatotic liver disease (MASLD).

The authors probed Medicare Part B data to explore outpatient clinical procedures performed by physician associates and nurse practitioners and report the trends from 2014 through 2021.

The data showed notable responses, even among patients living with chronic lymphocytic leukemia (CLL) who had previous exposure to B-cell receptor–associated kinase inhibitors, the authors said.

Patients with moderate to severe psoriasis and a history of cancer have improved symptoms and a favorable safety profile with guselkumab treatment, according to a new study.

Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine, discusses implementing value-based care initiatives in a pediatric dermatology practice.

A prospective study evaluating the efficacy of an artificial intelligence (AI)–based clinical support system further demonstrated the reliability of AI or machine learning as a diagnostic tool in skin cancer.